72.11.Z - Research and experimental development on biotechnology
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
62.01.Z - Computer programming activities
70.22.Z - Business and other management consultancy activities
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
2017 | 2018 | 2019 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 86,7 | 197,6 | 157,6 | -20,2 |
Gross profit (loss) | 5,2 | -23 | -36 | -56,8 |
Net profit (loss) | 5 | -23,1 | -36 | -56,1 |
Cash | 24,6 | 94,9 | 72,1 | -24 |
Liabilities and provisions for liabilities | 42 | 46 | 56,5 | 22,7 |
Net income from sale | 44,4 | 51,7 | 42,6 | -17,6 |
Short time liabilities | 15,4 | 20,8 | 25,2 | 21,2 |
Working assets | 43,2 | 148,1 | 90 | -39,2 |
Equity capital | 44,7 | 151,6 | 101,2 | -33,3 |
Operating profit (EBIT) | 5,9 | -24,3 | -45,1 | -85,4 |
% | % | % | p.p. | |
Equity capital to total assets | 51,6 | 76,7 | 64,2 | -12,5 |
Gross profit margin | 11,7 | -44,5 | -84,6 | -40,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 127 | 147 | 216 | 69 |
Current financial liquidity indicator | 1.3109594583511353 | 3.8064913749694824 | 1.7779839038848877 | -2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane